The patentability of human embryonic stem cell technology in China

Yaojin Peng*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.
Original languageEnglish
Pages (from-to)37-39
Number of pages3
JournalNature Biotechnology
Volume34
Issue number1
Early online date8 Jan 2016
DOIs
Publication statusPublished - Jan 2016

Fingerprint

Dive into the research topics of 'The patentability of human embryonic stem cell technology in China'. Together they form a unique fingerprint.

Cite this